Stack Builder

The most researched injury-repair protocol. BPC-157 drives local angiogenesis and tenocyte recruitment while TB-500 promotes systemic tissue remodelling via the actin-binding pathway.

The classic dual-mechanism GH secretagogue stack. CJC-1295 (GHRH analogue) extends the GH pulse window while Ipamorelin (GHRP) delivers a clean pulse — together 4–6× the GH output of either alone.

Sports performance research protocol combining GH axis optimisation with comprehensive tissue protection. Builds lean mass while preventing the injuries that heavy training demands.

Advanced muscle protocol combining myostatin blockade (Follistatin-344), direct IGF-1 receptor activation (IGF-1 LR3), and GH axis stimulation — three non-overlapping anabolic pathways.

Foundation anabolic stack combining the Gold Standard GH stack with IGF-1 LR3's 20–30 hour half-life for sustained mTOR activation and satellite cell recruitment.

Aesthetic body recomposition protocol. GH axis drives lean mass preservation while Tesamorelin's FDA-backed visceral fat reduction and AOD-9604's direct lipolysis target stubborn adiposity.

Dual-mechanism fat loss combining tirzepatide's GLP-1/GIP dual agonism (−20.9% body weight in Phase 3) with AOD-9604's β3-adrenergic direct lipolysis for comprehensive metabolic effect.

Novo Nordisk's investigational combination. Phase 3 REDEFINE trial: −22.7% body weight at 68 weeks. Amylin receptor agonism (cagrilintide) adds independent satiety pathway to GLP-1R.

Addresses the primary limitation of GLP-1 therapy: GI side effects. BPC-157 provides independent mucosal protection via 40+ GI studies, allowing better tolerability through dose escalation.

The classic Soviet-developed cognitive stack. Semax delivers BDNF upregulation and dopamine activation while Selank provides serotonergic anxiolysis — balanced stimulation without anxiety.

Three-timescale cognitive protocol: Semax for immediate neurotransmitter optimisation, Dihexa for synaptic density amplification via HGF/Met, and P21 for structural adult neurogenesis.

Comprehensive stress and anxiety protocol. Selank balances serotonin, KPV suppresses NF-κB inflammation, DSIP restores slow-wave sleep, and VIP shifts the autonomic nervous system toward parasympathetic tone.

Comprehensive cellular longevity protocol. Epitalon maintains telomeres, NAD⁺ drives sirtuin activation, GHK-Cu rebuilds the extracellular matrix, and SS-31 protects mitochondrial cristae.

Targets all three root causes of skin aging: collagen matrix loss (GHK-Cu), microvascular decline (BPC-157), and cellular senescence via telomere shortening (Epitalon).

Most studied IBD and gut repair protocol. BPC-157 drives angiogenic mucosal healing while KPV directly suppresses NF-κB inflammatory signalling — complementary mechanisms for comprehensive gut repair.

Most comprehensive post-surgical and post-injury protocol. Extends Wolverine with GHK-Cu for collagen quality and Thymosin Alpha-1 for immune surveillance and debris clearance.

Targets all three sleep-related GH axes: Ipamorelin maximises the natural nocturnal GH pulse, DSIP restores slow-wave sleep, and Epitalon normalises pineal melatonin for circadian regulation.

Covers all three arms of immunity: Thymosin Alpha-1 for adaptive T-cell maturation, LL-37 for innate antimicrobial defence against bacteria and fungi, VIP for cytokine balance and immune regulation.

HPG + GH dual-axis protocol. Gonadorelin maintains pulsatile GnRH signalling (preserving LH, FSH, and testosterone production) while Ipamorelin optimises GH without suppressing the HPG axis.

Combines PT-141's central melanocortin-driven arousal mechanism with oxytocin's pro-bonding and social facilitation effects. PT-141 is FDA-approved (Vyleesi) for female HSDD.